Dendritic cell-based vaccines for the therapy of experimental tumors

E Pajtasz-Piasecka, M Indrová - Immunotherapy, 2010 - Future Medicine
Dendritic cells (DCs) are believed to be the most potent antigen-presenting cells able to link
the innate and adaptive immune systems. Many studies have focused on different …

Dendritic cell-based vaccine research against cancer

N Mody, S Dubey, R Sharma, U Agrawal… - Expert review of clinical …, 2015 - Taylor & Francis
Therapeutic vaccines that treat cancers with the help of the patient's own immune system
signify a feasible option for active immunotherapy against the disease. Dendritic cells (DCs) …

Optimizing dendritic cell-based immunotherapy for cancer

H Zhong, MR Shurin, B Han - Expert review of vaccines, 2007 - Taylor & Francis
Dendritic cells (DCs) are the most powerful professional antigen-presenting cells and are
unique in their capability to initiate, maintain and regulate the intensity of primary immune …

Dendritic cell vaccines for cancer therapy

GM Sprinzl, L Kacani… - Cancer …, 2001 - cancertreatmentreviews.com
Dendritic cells (DC) are professional antigen-presenting cells whose primary function is the
initiation of immune response. Based on the finding that the immune system usually fails to …

[HTML][HTML] Distinct features of dendritic cell-based immunotherapy as cancer vaccines

C Lee, M Lee, I Rhee - Clinical and Experimental Vaccine …, 2018 - ncbi.nlm.nih.gov
Dendritic cells (DCs) are the most professional antigen presenting cells that play important
roles in connection between innate and adaptive immune responses. Numerous studies …

[HTML][HTML] Antitumor vaccines based on dendritic cells: from experiments using animal tumor models to clinical trials

OV Markov, NL Mironova, VV Vlassov - Acta Naturae …, 2017 - cyberleninka.ru
The routine methods used to treat oncological diseases have a number of drawbacks,
including non-specific action and severe side effects for patients. Furthermore, tumor …

[HTML][HTML] Dendritic cells in cancer vaccines

P Brossart, S Wirths, W Brugger, L Kanz - Experimental hematology, 2001 - Elsevier
Dendritic cells (DC) are recognized as the most potent antigen-presenting cells with the
ability to stimulate naive resting T cells and to initiate primary immune responses …

[HTML][HTML] Dendritic cells in anticancer vaccination: rationale for ex vivo loading or in vivo targeting

AV Baldin, LV Savvateeva, AV Bazhin, AA Zamyatnin Jr - Cancers, 2020 - mdpi.com
Dendritic cells (DCs) have shown great potential as a component or target in the landscape
of cancer immunotherapy. Different in vivo and ex vivo strategies of DC vaccine generation …

Personalized dendritic cell-based tumor immunotherapy

N Janikashvili, N Larmonier, E Katsanis - Immunotherapy, 2010 - Future Medicine
Advances in the understanding of the immunoregulatory functions of dendritic cells (DCs) in
animal models and humans have led to their exploitation as anticancer vaccines. Although …

Advances in dendritic cell-based vaccine of cancer

X Zhang, JR Gordon, J Xiang - Cancer Biotherapy and …, 2002 - liebertpub.com
Dendritic cells (DCs) are potent antigen presenting cells that exist in virtually every tissue,
and from which they capture antigens and migrate to secondary lymphoid organs where …